XRTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
XORTX Therapeutics Inc (XRTX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's financial performance is weak, with significant losses in net income and EPS. There are no strong technical or trading signals, and the stock lacks positive catalysts to drive growth in the near term. Holding off on investment until there are clearer signs of improvement is recommended.
The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 2.679, with resistance at 3.287 and support at 2.072.
The company recently regained compliance with Nasdaq's listing requirements, which could improve investor confidence.
Weak financial performance with significant YoY declines in net income (-581.87%) and EPS (-336.84%). No significant insider or hedge fund trading activity. Pre-market price is down 0.72%, and there are no strong technical or trading signals.
In Q4 2025, revenue remained at 0 with no growth YoY. Net income dropped significantly to -590,462 (-581.87% YoY), and EPS fell to -0.45 (-336.84% YoY). Gross margin remains at 0 with no improvement.
No data on analyst ratings or price target changes is available.
